Last $61.95 USD
Change Today +0.42 / 0.68%
Volume 1.2M
ENDP On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
Toronto
As of 2:30 PM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Julie H. McHugh

Director and Member of Audit Committee, Ironwood Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 156 board members in 4 different organizations across 6 different industries.

See Board Relationships
49--

Background*

Ms. Julie H. McHugh served as the Chief Operating Officer of Endo Pharmaceuticals Holdings Inc. from March 13, 2010 to May 29, 2013 and its subsidiary, Endo Pharmaceuticals Solutions Inc. from March 2010 to May 29, 2013. Ms. McHugh is a 23-year veteran of the biopharmaceutical industry. She served as the Chief Executive Officer and President of Nora Therapeutics, Inc. Prior to Nora Therapeutics, she served as Company Group Chairman for Worldwide Virology Business Unit ...

Read Full Background

Corporate Headquarters*

Glandore Business Centres
Dublin, Co. Dublin 2

Ireland

Phone: 353 1 699 4700
Fax: --

Board Members Memberships*

Director
Director
Former Chief Executive Officer
2010-Present
Director
2012-2014
Former Director and Member of Compensation Committee
2014-Present
Director and Member of Audit Committee

Education*

BS
Pennsylvania State University
MBA
Saint Joseph's University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENDP:US $61.95 USD +0.42

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rick E. Winningham Chairman, Chief Executive Officer, Member of Stock Option Committee and Member of Science & Technology Advisory Committee
Theravance Inc.
$986.9K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$807.7K
Mark R. Baker J.D.Chief Executive Officer, Director, Member of Science & Technology Committee and Member of Strategy & External Technology Subcommittee
Progenics Pharmaceuticals, Inc.
$672.8K
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
--
Richard Martin Steeves BSc., Ph.D.Group Chief Executive Officer, Member of Senior Executive Board and Executive Director
Synergy Health plc
778.0K GBP
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENDO HEALTH SOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.